Health-related quality of life after treatment for bladder cancer in England
| Autor: | Samantha J Mason, Luke Hounsome, James W.F. Catto, Amy Downing, Penny Wright, Michael J Richards, Adam Glaser, Jessica Corner, Sarah Bottomley |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Adult
Male Cancer Research medicine.medical_specialty medicine.medical_treatment Urinary system Population 030232 urology & nephrology Comorbidity Cystectomy Article 03 medical and health sciences 0302 clinical medicine Quality of life Surveys and Questionnaires Internal medicine medicine Humans Patient Reported Outcome Measures education Aged Aged 80 and over education.field_of_study Bladder cancer Radiotherapy business.industry Cancer Endoscopy Middle Aged medicine.disease Radiation therapy England Urinary Bladder Neoplasms Oncology 030220 oncology & carcinogenesis Quality of Life Female business |
| Zdroj: | British Journal of Cancer |
| ISSN: | 0007-0920 1532-1827 |
| Popis: | Background: Little is known about quality of life after bladder cancer treatment. This common cancer is managed using treatments that can affect urinary, sexual and bowel function.\ud \ud \ud \ud Methods: To understand quality of life and inform future care, the Department of Health (England) surveyed adults surviving bladder cancer 1–5 years after diagnosis. Questions related to disease status, co-existing conditions, generic health (EQ-5D), cancer-generic (Social Difficulties Inventory) and cancer-specific outcomes (Functional Assessment of Cancer Therapy—Bladder).\ud \ud \ud \ud Results: In total, 673 (54%) patients responded; including 500 (74%) men and 539 (80%) with co-existing conditions. Most respondents received endoscopic treatment (60%), while 92 (14%) and 99 (15%) received radical cystectomy or radiotherapy, respectively. Questionnaire completion rates varied (51–97%). Treatment groups reported ≥1 problem using EQ-5D generic domains (59–74%). Usual activities was the most common concern. Urinary frequency was common after endoscopy (34–37%) and radiotherapy (44–50%). Certain populations were more likely to report generic, cancer-generic and cancer-specific problems; notably those with co-existing long-term conditions and those treated with radiotherapy.\ud \ud \ud \ud Conclusion: The study demonstrates the importance of assessing patient-reported outcomes in this population. There is a need for larger, more in-depth studies to fully understand the challenges patients with bladder cancer face. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink